The sixth Covid vaccine is also the first whole-virus inactive Covid vaccine to gain regulatory approval in the UK. This is where the virus is grown in a laboratory and then made completely inactive. Doctor June Raine, MHRA Chief Executive, said: “Our approval of the COVID-19 vaccine made by Valneva today follows a rigorous review of the safety, quality and effectiveness of this vaccine.” Co-signed by the Commission on Human Medicines, the chair of the body, Professor Sir Munir Pirmohamed said: “We have advised that the benefit risk balance is positive.”
